Fast Five Quiz: Advanced and Metastatic Prostate Cancer Treatment

Daniel S. Schwartz, MD, MBA

Disclosures

January 29, 2020

Despite multiple new drug approvals and an evolving treatment paradigm, the management of prostate cancer remains a major global healthcare challenge. In 2018, nearly 360,000 deaths worldwide were attributed to prostate cancer, and that number is expected to double over the next 20 years. Most prostate cancer–related deaths are due to advanced disease, which results from any combination of lymphatic, hematogenous, or contiguous local spread. The treatment of locally advanced and metastatic prostate cancer is becoming increasing complex. Although metastatic prostate cancer remains uncurable, effective treatment may delay progression and extend survival.

Are you familiar with key aspects of the management of patients with advanced and metastatic prostate cancer? Refresh your knowledge with this quick quiz.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....